Status:
ENROLLING_BY_INVITATION
Tranexamic Acid Infusion During Elective Spine Surgery
Lead Sponsor:
Albany Medical College
Conditions:
Spine Surgery
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Tranexamic acid (TXA) is an agent that has been shown to be safe and effective to reduce blood loss in surgical procedures. The purpose of the study is to assess the effect of transexamic on elective ...
Detailed Description
This will be a prospective randomized control, double-blinded investigation. The Investigators will recruit patients undergoing elective, primary, decompressive lumbar surgery via a posterior surgical...
Eligibility Criteria
Inclusion
- Patients undergoing decompressive lumbar laminectomy with or without fusion
- Primary surgical procedure
- Competent adult able to give informed consent
- Age \>18
Exclusion
- h/o DVT or PE
- h/o seizure
- h/o coagulopathy
- Diagnosis of malignancy or infection as indication for surgical decompression
- Abnormal pre-operative PT/INR, aPTT, bleeding time
- Platelet count \< 100
- Patients requiring therapeutic heparin or lovenox bridges prior to and/or after surgery
- Allergy to TXA
- Pregnant women and prisoners
- Renal insufficiency
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT04312880
Start Date
December 1 2018
End Date
January 1 2021
Last Update
August 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albany Medical Center
Albany, New York, United States, 12208